Contact
Please use this form to send email to PR contact of this press release:
REACX PHARMACEUTICALS AWARDED $10.35 MILLION GRANT TO ADVANCE NALMEFENE IMPLANT FOR OPIOID RELAPSE PREVENTION
TO:
Rajesh Patel
ReacX Pharmaceuticals, Inc
+1 650-438-5769